• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

World’s first total-body PET scanner

, 26 August 2020/in E-News /by 3wmedia

Scientists from the Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) have set out to help build the world’s first total-body positron emission tomography (PET) scanner, a medical imaging device that could change the way cancers and other diseases are diagnosed and treated.
The project is a consortium led by a UC Davis research team and includes scientists from Berkeley Lab and the University of Pennsylvania. It’s supported by a recently announced five-year, $15.5 million ( Euro 13 million) Transformative Research Award from the National Institutes of Health.
The consortium’s goal is to build a PET scanner that images the entire human body simultaneously, a big jump from today’s PET scanners that only scan 20-cm segments at a time. In addition to being able to diagnose and track the trajectory of a disease in a way not possible today, a total-body PET scanner would reduce a patient’s radiation dose by a factor of 40, or decrease scanning time from 20 minutes to just 30 seconds.
Berkeley Lab’s contribution, led by William Moses of the Molecular Biophysics and Integrated Bioimaging Division, is to develop electronics that send data collected by the scanner’s detectors to a computer, which converts the data into a three-dimensional image of the patient. The new scanner will have half a million detectors, and the data from each detector must be electronically transmitted to a computer, so the task is incredibly complex.
‘We’re developing the electronic interface between the detectors and the computer algorithm-and the electronics for this scanner is an order of magnitude more complicated than what’s been done before,’ says Moses. ‘But Berkeley Lab has a long history developing instrumentation for nuclear medical imaging, including PET scanners, and this project is another milestone in our research.’
The total-body PET scanner is the latest project in Berkeley Lab’s PET-related research, coming at a time when technology has advanced to the point that it s possible to efficiently process the data generated from the scanner’s half a million detectors.

Lawrence Berkeley National Laboratoryhttp://tinyurl.com/zyqhukj

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:30World’s first total-body PET scanner

An implant to prevent Alzheimer’s

, 26 August 2020/in E-News /by 3wmedia

The lab of Patrick Aebischer at EPFL has developed a bioactive capsule containing cells that have been genetically engineered to produce antibodies against Abeta. The capsule is implanted in the tissue under the skin, and over time the cells produce and release a steady flow of antibodies into the bloodstream, from where they cross over into the brain to target the Abeta plaques.
Before going into capsule, the cells are first genetically engineered to produce antibodies that specifically recognize and target Abeta. The cells of choice are taken from muscle tissue, and the permeable membranes let them interact with the surrounding tissue to get all the nutrients and molecules they need.

EPFL
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:39An implant to prevent Alzheimer’s

Cholesterol-lowering statins may lower risk of heart disease in people with apnoea

, 26 August 2020/in E-News /by 3wmedia

A new study conducted at Columbia University Medical Center (CUMC) has revealed some of the underlying mechanisms that may increase the risk of heart disease in people with sleep apnoea. The study also found that statins

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:47Cholesterol-lowering statins may lower risk of heart disease in people with apnoea

SPECT-MRI fusion minimizes surgery for diagnosis of early-stage cervical cancer patients

, 26 August 2020/in E-News /by 3wmedia

A recent study found that cervical cancer patients without enlarged lymph nodes could benefit from SPECT-MRI imaging of their sentinel lymph nodes (SLNs) to assess whether metastases are present.

Cervical cancer is the fourth most common cancer in women worldwide, with more than 500,000 new cases globally each year. According to a 2014 University of Maryland study, cervical cancer affects 18.6 women per 100,000 in the United States. Early diagnosis is critical. Although surgical removal and examination of the sentinel lymph nodes remains the most accurate way to determine whether the cancer has spread to the lymph nodes, SPECT-MRI imaging may reduce false negative MRI findings in early-stage patients and potentially save some from invasive diagnostic procedures.

Researchers at the University Medical Center Utrecht, Netherlands, used Tc-99m-nanocolloid SPECT-MRI fusion for the assessment of SLNs (for size and absence of sharp demarcation) in patients with early-stage cervical cancer.

 Jacob P. Hoogendam, MD, the corresponding author of the study, notes,

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:33SPECT-MRI fusion minimizes surgery for diagnosis of early-stage cervical cancer patients

The conhIT AppCircus goes in search of the best health app

, 26 August 2020/in E-News /by 3wmedia

At conhIT – Connecting Healthcare IT, Europe’s leading event for the Health IT industry which takes place from 19 to 21 April in Berlin – a competition will be presenting an award for the best health app once again.
This event, part of the internationally recognized AppCircus series, will be taking place for the second time, and is regarded as the world’s biggest competition for mHealth apps. Taking part gives companies and mHealth app developers an opportunity to present their products to an outstanding audience and to increase awareness of their companies in the Health IT sector. At conhIT 2016 more than 7,500 visitors and some 400 exhibitors are expected to attend.
The competition will be looking for an app that assists the daily work of medical professionals, nurses and patients and can be used in Europe in hospitals, rehab centres, care homes and general patient care.
The award ceremony will take place on 20 April 2016 in the mobile health zone at conhIT. This section of the exhibition focuses on innovations and trends in mobile health applications.   
The winner of the conhIT AppCircus competition will be nominated for the Mobile Premier Awards, the world’s biggest app exhibition at the Mobile World Congress in Barcelona.
www.conhit.com

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:41The conhIT AppCircus goes in search of the best health app

Optimal care for older cancer patients should target relevant HRQOL domains

, 26 August 2020/in E-News /by 3wmedia

In a paper recently published, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients.

Dr. Andrew Bottomley, Head of the EORTC Quality of Life Department and senior  investigator of this study says,

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:50Optimal care for older cancer patients should target relevant HRQOL domains

Hybrid molecule delivers a blow to malignant cells

, 26 August 2020/in E-News /by 3wmedia

A new hybrid molecule developed in the lab at the NYU Tandon School of Engineering shows promise for treating breast cancer by serving as a

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:36Hybrid molecule delivers a blow to malignant cells

Breast screening programme effective in preventing some invasive cancers

, 26 August 2020/in E-News /by 3wmedia

Ductal carcinoma in situ (DCIS) is described as a very early form of breast cancer, where cancer cells are present in milk ducts, but have not yet invaded the surrounding breast tissue. Around 4,800 people are diagnosed with DCIS in the UK each year and the main form of treatment is surgery followed by radiotherapy.
Ongoing public debate about the harm caused by mammography screening through over-diagnosis has led to controversy over the value of screening for and treatment of DCIS. A major question has been the extent to which diagnosis and treatment of DCIS may prevent the occurrence of invasive breast cancer in the future.
The researchers analysed data on 5,243,658 women aged 50-64 who were screened over a four year period across 84 screening units in the UK

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:44Breast screening programme effective in preventing some invasive cancers

New syringe design not particularly effective at curbing spread of Hepatitis C virus

, 26 August 2020/in E-News /by 3wmedia

Researchers examined the internal design of syringes to see if variations affected the transmission of hepatitis C virus.
As many as 21 million people worldwide inject drugs, putting them at heightened risk for infection from blood-borne pathogens such as the hepatitis C virus (HCV), especially if syringes are shared.

A newer type of syringe designed to reduce HCV transmission by decreasing the so-called dead space

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:52New syringe design not particularly effective at curbing spread of Hepatitis C virus

Personalized heart models for surgical planning

, 26 August 2020/in E-News /by 3wmedia

Researchers at MIT and Boston Children’s Hospital have developed a system that can take MRI scans of a patient’s heart and, in a matter of hours, convert them into a tangible, physical model that surgeons can use to plan surgery.
The models could provide a more intuitive way for surgeons to assess and prepare for the anatomical idiosyncrasies of individual patients. ‘Our collaborators are convinced that this will make a difference,’ says Polina Golland, a professor of electrical engineering and computer science at MIT, who led the project. ‘The phrase I heard is that surgeons see with their hands,’ that the perception is in the touch.’
This fall, seven cardiac surgeons at Boston Children’s Hospital will participate in a study intended to evaluate the models’ usefulness.
Danielle Pace, an MIT graduate student in electrical engineering and computer science, is first author on the paper and spearheaded the development of the software that analyses the MRI scans. Mehdi Moghari, a physicist at Boston Children’s Hospital, developed new procedures that increase the precision of MRI scans tenfold, and Andrew Powell, a cardiologist at the hospital, leads the project’s clinical work.
MRI data consist of a series of cross sections of a three-dimensional object. Like a black-and-white photograph, each cross section has regions of dark and light, and the boundaries between those regions may indicate the edges of anatomical structures. Then again, they may not.
Determining the boundaries between distinct objects in an image is one of the central problems in computer vision, known as ‘image segmentation.’ But general-purpose image-segmentation algorithms aren’t reliable enough to produce the very precise models that surgical planning requires.
Typically, the way to make an image-segmentation algorithm more precise is to augment it with a generic model of the object to be segmented. Human hearts, for instance, have chambers and blood vessels that are usually in roughly the same places relative to each other. That anatomical consistency could give a segmentation algorithm a way to weed out improbable conclusions about object boundaries.
The problem with that approach is that many of the cardiac patients at Boston Children’s Hospital require surgery precisely because the anatomy of their hearts is irregular. Inferences from a generic model could obscure the very features that matter most to the surgeon.
In the past, researchers have produced printable models of the heart by manually indicating boundaries in MRI scans. But with the 200 or so cross sections in one of Moghari’s high-precision scans, that process can take eight to 10 hours.
‘They want to bring the kids in for scanning and spend probably a day or two doing planning of how exactly they’re going to operate,’ Golland says. ‘If it takes another day just to process the images, it becomes unwieldy.’
Pace and Golland’s solution was to ask a human expert to identify boundaries in a few of the cross sections and allow algorithms to take over from there. Their strongest results came when they asked the expert to segment only a small patch -one-ninth of the total area – of each cross section.
In that case, segmenting just 14 patches and letting the algorithm infer the rest yielded 90 percent agreement with expert segmentation of the entire collection of 200 cross sections. Human segmentation of just three patches yielded 80 percent agreement.
‘I think that if somebody told me that I could segment the whole heart from eight slices out of 200, I would not have believed them,’ Golland says. ‘It was a surprise to us.’
Together, human segmentation of sample patches and the algorithmic generation of a digital, 3-D heart model takes about an hour. The 3-D-printing process takes a couple of hours more.
Currently, the algorithm examines patches of unsegmented cross sections and looks for similar features in the nearest segmented cross sections. But Golland believes that its performance might be improved if it also examined patches that ran obliquely across several cross sections. This and other variations on the algorithm are the subject of ongoing research.

MIThttp://tinyurl.com/pz4su4s

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:292020-08-26 14:38:30Personalized heart models for surgical planning
Page 155 of 229«‹153154155156157›»

Latest issue of International Hospital

April 2024

16 May 2025

Mindray launches premium ultrasound system to enhance diagnostic capabilities

15 May 2025

World’s first personalised CRISPR therapy treats child with rare metabolic disorder

14 May 2025

Embedded therapist significantly reduces ICU nurse burnout

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription